Correspondence (letter to the editor): Treatment Option not Mentioned

Autor Ezziddin, Samer, Biersack, Hans-Jürgen
Vydáno 2013

Correspondence (letter to the editor): Radioembolization as a Treatment Option

Autor Ezziddin, Samer, Bücker, Arno, Lammert, Frank
Vydáno v Dtsch Arztebl Int (2015)

Diagnosis of extra-adrenal phaeochromocytoma after nephrectomy

Autor Barski, Dimitri, Ezziddin, Samer, Heikaus, Sebastian, Neumann, Hartmut P.H.
Vydáno 2014

Successful radiopeptide targeting of metastatic anaplastic meningioma: Case report

Autor Biersack Hans-Jürgen, Wilinek Winfried, Herrlinger Ulrich, Ahmadzadehfar Hojjat, Sabet Amir, Ezziddin Samer
Vydáno 2011-08-01

Successful radiopeptide targeting of metastatic anaplastic meningioma: Case report

Autor Sabet, Amir, Ahmadzadehfar, Hojjat, Herrlinger, Ulrich, Wilinek, Winfried, Biersack, Hans-Jürgen, Ezziddin, Samer
Vydáno 2011

Repeated Radionuclide therapy in metastatic paraganglioma leading to the highest reported cumulative activity of (131)I-MIBG

Autor Ezziddin, Samer, Sabet, Amir, Ko, Yon-Dschun, Xun, Sunny, Matthies, Alexander, Biersack, Hans-Jürgen
Vydáno 2012

May bone-targeted radionuclide therapy overcome PRRT-refractory osseous disease in NET? A pilot report on (188)Re-HEDP treatment in progressive bone metastases after (177)Lu-octreo...

Autor Sabet, Amir, Khalaf, Feras, Mahjoob, Soha, Al-Zreiqat, Abdullah, Biersack, Hans-Jürgen, Ezziddin, Samer
Vydáno 2013

Does PRRT with standard activities of (177)Lu-octreotate really achieve relevant somatostatin receptor saturation in target tumor lesions?: insights from intra-therapeutic receptor...

Autor Sabet, Amir, Nagarajah, James, Dogan, Ahmet Semih, Biersack, Hans-Jürgen, Sabet, Amin, Guhlke, Stefan, Ezziddin, Samer
Vydáno 2013

Molecular imaging and biochemical response assessment after a single cycle of [(225)Ac]Ac-PSMA-617/[(177)Lu]Lu-PSMA-617 tandem therapy in mCRPC patients who have progressed on [(17...

Autor Rosar, Florian, Hau, Fabian, Bartholomä, Mark, Maus, Stephan, Stemler, Tobias, Linxweiler, Johannes, Ezziddin, Samer, Khreish, Fadi
Vydáno v Theranostics (2021)

Renal Safety of [(177)Lu]Lu-PSMA-617 Radioligand Therapy in Patients with Compromised Baseline Kidney Function

Autor Rosar, Florian, Kochems, Niklas, Bartholomä, Mark, Maus, Stephan, Stemler, Tobias, Linxweiler, Johannes, Khreish, Fadi, Ezziddin, Samer
Vydáno v Cancers (Basel) (2021)

Determination of split renal function by PSMA imaging: comparison of (68)Ga-PSMA-11 PET with (99m)Tc-MAG3 scintigraphy

Autor Rosar, Florian, Pauly, Peter, Ries, Martin, Schaefer-Schuler, Andrea, Maus, Stephan, Schreckenberger, Mathias, Khreish, Fadi, Ezziddin, Samer
Vydáno v Am J Nucl Med Mol Imaging (2020)

Neuron-specific enolase has potential value as a biomarker for [(18)F]FDG/[(68)Ga]Ga-PSMA-11 PET mismatch findings in advanced mCRPC patients

Autor Rosar, Florian, Ribbat, Kalle, Ries, Martin, Linxweiler, Johannes, Bartholomä, Mark, Maus, Stephan, Schreckenberger, Mathias, Ezziddin, Samer, Khreish, Fadi
Vydáno v EJNMMI Res (2020)

Proof-of-Concept Study of the NOTI Chelating Platform: Preclinical Evaluation of (64)Cu-Labeled Mono- and Trimeric c(RGDfK) Conjugates

Autor Martin, Sebastian, Maus, Stephan, Stemler, Tobias, Rosar, Florian, Khreish, Fadi, Holland, Jason P., Ezziddin, Samer, Bartholomä, Mark D.
Vydáno v Mol Imaging Biol (2020)

Efficacy and Safety of [(225)Ac]Ac-PSMA-617 Augmented [(177)Lu]Lu-PSMA-617 Radioligand Therapy in Patients with Highly Advanced mCRPC with Poor Prognosis

Autor Rosar, Florian, Krause, Jonas, Bartholomä, Mark, Maus, Stephan, Stemler, Tobias, Hierlmeier, Ina, Linxweiler, Johannes, Ezziddin, Samer, Khreish, Fadi
Vydáno v Pharmaceutics (2021)

Efficacy of peptide receptor radionuclide therapy with (177)Lu-octreotate in metastatic pulmonary neuroendocrine tumors: a dual-centre analysis

Autor Sabet, Amir, Haug, Alexander R, Eiden, Collin, Auernhammer, Christoph J, Simon, Birgit, Bartenstein, Peter, Biersack, Hans J, Ezziddin, Samer
Vydáno v Am J Nucl Med Mol Imaging (2017)

Comparison of different methods for post-therapeutic dosimetry in [(177)Lu]Lu-PSMA-617 radioligand therapy

Autor Rosar, Florian, Schön, Niklas, Bohnenberger, Hendrik, Bartholomä, Mark, Stemler, Tobias, Maus, Stephan, Khreish, Fadi, Ezziddin, Samer, Schaefer-Schuler, Andrea
Vydáno v EJNMMI Phys (2021)

EANM guidelines for radionuclide therapy of bone metastases with beta-emitting radionuclides

Autor Handkiewicz-Junak, Daria, Poeppel, Thorsten D., Bodei, Lisa, Aktolun, Cumali, Ezziddin, Samer, Giammarile, Francesco, Delgado-Bolton, Roberto C., Gabriel, Michael
Vydáno v Eur J Nucl Med Mol Imaging (2018)

Bone metastases in GEP-NET: response and long-term outcome after PRRT from a follow-up analysis

Autor Sabet, Amir, Khalaf, Feras, Haslerud, Torjan, Al-Zreiqat, Abdullah, Sabet, Amin, Simon, Birgit, Pöppel, Thorsten D, Biersack, Hans-Jürgen, Ezziddin, Samer
Vydáno 2013

The Impact of Diffusion-Weighted MRI on the Definition of Gross Tumor Volume in Radiotherapy of Non-Small-Cell Lung Cancer

Autor Fleckenstein, Jochen, Jelden, Michael, Kremp, Stephanie, Jagoda, Philippe, Stroeder, Jonas, Khreish, Fadi, Ezziddin, Samer, Buecker, Arno, Rübe, Christian, Schneider, Guenther K.
Vydáno v PLoS One (2016)

Interim analysis of the REASSURE (Radium-223 alpha Emitter Agent in non-intervention Safety Study in mCRPC popUlation for long-teRm Evaluation) study: patient characteristics and s...

Autor Dizdarevic, Sabina, Petersen, Peter Meidahl, Essler, Markus, Versari, Annibale, Bourre, Jean-Cyril, la Fougère, Christian, Valdagni, Riccardo, Paganelli, Giovanni, Ezziddin, Samer, Kalinovský, Ján, Bayh, Inga, Du, Yong
Vydáno v Eur J Nucl Med Mol Imaging (2019)